Breaking News
Get 50% Off 0
📈 Q2 Earnings Alert! Plan ahead with key data on upcoming stock reports - all in 1 place
See Calendar
Close

Jafron Biomedical Co Ltd (300529)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
23.55 -0.56    -2.32%
08:44:59 - Closed. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE100002995 
  • Volume: 15,165,528
  • Bid/Ask: 23.55 / 23.58
  • Day's Range: 23.41 - 24.24
Jafron Biomedical 23.55 -0.56 -2.32%

Jafron Biomedical Co Ltd Company Profile

 
Get an in-depth profile of Jafron Biomedical Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

2408

Equity Type

ORD

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sales of blood purification products for hemadsorption field in worldwide. The company provides solutions for ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, kidney, and liver diseases. It offers HA series hemoperfusion cartridge, BS series bilirubin adsorption column and DNA immunoadsorption column, hemoperfusion machine, and blood purification machine; and other products, such as hemodialyzer, disinfectants, hemodialysis concentrate, resin bandages, online hemodialysis powder bag/bucket, and adsorbable suture with needles, as well as syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Contact Information

Address No. 98 Technology Six Road High-tech Zone
Zhuhai, 519085
China
Phone 86 75 6368 9708
Fax 86 75 6361 9363

Top Executives

Name Age Since Title
Zhihao Wen 58 2023 Independent Director
Xian Min Tang 55 2010 Deputy GM & Director
Fan Dong 55 2010 Chairman of Board of Directors & GM
Xueyun Liao 48 2023 Director & Financial Director
John R. Prowle - 2021 Member of Global Advisory Board
Wen Lei 54 2020 Non-Independent Director
Feng Li 55 2017 Deputy GM & Non-Independent Director
Thomas Rimmelé - 2021 Member of Global Advisory Board
Claudio Ronco - 2021 Member of Global Advisory Board
Antoine Schneider - 2021 Member of Global Advisory Board
Yingjuan Shen 41 2023 Supervisor
Rinaldo Bellomo - 2021 Member of Global Advisory Board
Qingwu Xie 43 2023 Non-Independent Director
Zhi Hao Wen 59 2023 Independent Director
Olivier Joannes-Boyau - 2021 Member of Global Advisory Board
Xiaohong Peng 65 2017 Chairman of Supervisory Board
Guoqing Guo 63 2023 Independent Director
Yanjun Xu 52 2023 Independent Director
Yaohong Chen 46 2017 Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

300529 Comments

Write your thoughts about Jafron Biomedical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email